These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16293350)

  • 21. A comparative molecular field analysis of cytotoxic beta-carboline analogs.
    Hou XR; Chen Q; Cao RH; Peng WL; Xu AL
    Acta Pharmacol Sin; 2004 Jul; 25(7):959-65. PubMed ID: 15210072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D QSAR models for alpha2a-adrenoceptor agonists.
    Balogh B; Jójárt B; Wágner Z; Kovács P; Máté G; Gyires K; Zádori Z; Falkay G; Márki A; Viskolcz B; Mátyus P
    Neurochem Int; 2007 Oct; 51(5):268-76. PubMed ID: 17643557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bridgehead-methyl analog of SC-53116 as a 5-HT4 agonist.
    Becker DP; Flynn DL; Villamil CI
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3073-5. PubMed ID: 15149647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpretation of scoring functions using 3D molecular fields. Mapping the diacyl-hydrazine-binding pocket of an insect ecdysone receptor.
    Bordas B; Belai I; Lopata A; Szanto Z
    J Chem Inf Model; 2007; 47(1):176-85. PubMed ID: 17238263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT4 receptor agonists: similar but not the same.
    De Maeyer JH; Lefebvre RA; Schuurkes JA
    Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
    Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q
    Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test case.
    Yasuo K; Yamaotsu N; Gouda H; Tsujishita H; Hirono S
    J Chem Inf Model; 2009 Apr; 49(4):853-64. PubMed ID: 19391630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
    Chaudhaery SS; Roy KK; Saxena AK
    J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach.
    Cellek S; Thangiah R; Jarvie EM; Vivekanandan S; Lalude O; Sanger GJ
    Neurogastroenterol Motil; 2008 May; 20(5):539-45. PubMed ID: 18194150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons.
    Mlinar B; Mascalchi S; Mannaioni G; Morini R; Corradetti R
    Eur J Neurosci; 2006 Aug; 24(3):719-31. PubMed ID: 16930402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.
    Zou JW; Luo CC; Zhang HX; Liu HC; Jiang YJ; Yu QS
    J Mol Graph Model; 2007 Sep; 26(2):494-504. PubMed ID: 17418602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
    Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K
    Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
    Ravindra GK; Achaiah G; Sastry GN
    Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.
    Castriconi F; Paolino M; Giuliani G; Anzini M; Campiani G; Mennuni L; Sabatini C; Lanza M; Caselli G; De Rienzo F; Menziani MC; Sbraccia M; Molinari P; Costa T; Cappelli A
    Eur J Med Chem; 2014 Jul; 82():36-46. PubMed ID: 24871995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors.
    Blaazer AR; Smid P; Kruse CG
    ChemMedChem; 2008 Sep; 3(9):1299-309. PubMed ID: 18666267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors.
    Pellissier LP; Sallander J; Campillo M; Gaven F; Queffeulou E; Pillot M; Dumuis A; Claeysen S; Bockaert J; Pardo L
    Mol Pharmacol; 2009 Apr; 75(4):982-90. PubMed ID: 19168624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the quality of 3D-QSAR by using flexible-ligand receptor models.
    Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L
    J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
    Sheng C; Zhang W; Ji H; Zhang M; Song Y; Xu H; Zhu J; Miao Z; Jiang Q; Yao J; Zhou Y; Zhu J; Lü J
    J Med Chem; 2006 Apr; 49(8):2512-25. PubMed ID: 16610794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.